Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
Genetics in Medicine · 2024
DOI: 10.1016/j.gim.2023.101032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine, 2024. Verfasst von Roelof Koster und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: r.koster@nki.nl. Hauptthemen laut MEDLINE: Genetic Counseling, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Netherlands Organisation for Health Research and Development.
Abstract (Originalsprache)
PURPOSE: Genome sequencing (GS) enables comprehensive molecular analysis of tumors and identification of hereditary cancer predisposition. According to guidelines, directly determining pathogenic germline variants (PGVs) requires pretest genetic counseling, which is cost-ineffective. Referral for genetic counseling based on tumor variants alone could miss relevant PGVs and/or result in unnecessary referrals. METHODS: We validated GS for detection of germline variants and simulated 3 strategies using paired tumor-normal GS data of 937 metastatic patients. In strategy-1, genetic counseling before tumor testing allowed direct PGV analysis. In strategy-2 and -3, germline testing and referral for post-test genetic counseling is based on tumor variants using Dutch (strategy-2) or Europen Society for Medical Oncology (ESMO) Precision Medicine Working Group (strategy-3) guidelines. RESULTS: In strategy-1, PGVs would be detected in 50 patients (number-needed-to counsel; NTC = 18.7). In strategy-2, 86 patients would have been referred for genetic counseling and 43 would have PGVs (NTC = 2). In strategy-3, 94 patients would have been referred for genetic counseling and 32 would have PGVs (NTC = 2.9). Hence, 43 and 62 patients, respectively, were unnecessarily referred based on a somatic variant. CONCLUSION: Both post-tumor test counseling strategies (2 and 3) had significantly lower NTC, and strategy-2 had the highest PGV yield. Combining pre-tumor test mainstreaming and post-tumor test counseling may maximize the clinically relevant PGV yield and minimize unnecessary referrals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: r.koster@nki.nl.
- The Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Hartwig Medical Foundation, Amsterdam, The Netherlands.
- The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: k.monkhorst@nki.nl.
Förderung
- Netherlands Organisation for Health Research and Development
Zitieren
APA
Koster, R., Schipper, L. J., Giesbertz, N. A. A., van Beek, D., Mendeville, M., Samsom, K. G., Rosenberg, E. H., Hogervorst, F. B. L., Roepman, P., Boelens, M. C., Bosch, L. J. W., van den Berg, J. G., Meijer, G. A., Voest, E. E., Cuppen, E., Ruijs, M. W. G., van Wezel, T., van der Kolk, L., & Monkhorst, K. (2024). Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics. Genetics in Medicine. https://doi.org/10.1016/j.gim.2023.101032
Vancouver
Koster R, Schipper LJ, Giesbertz NAA, van Beek D, Mendeville M, Samsom KG, et al. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics. Genetics in Medicine. 2024. doi:10.1016/j.gim.2023.101032
BibTeX
@article{Koster2024,
author = {Koster, Roelof and Schipper, Luuk J and Giesbertz, Noor A A and van Beek, Daphne and Mendeville, Matías and Samsom, Kris G and Rosenberg, Efraim H and Hogervorst, Frans B L and Roepman, Paul and Boelens, Mirjam C and Bosch, Linda J W and van den Berg, Jose G and Meijer, Gerrit A and Voest, Emile E and Cuppen, Edwin and Ruijs, Marielle W G and van Wezel, Tom and van der Kolk, Lizet and Monkhorst, Kim},
title = {Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics},
journal = {Genetics in Medicine},
year = {2024},
doi = {10.1016/j.gim.2023.101032}
}
EUVIMED